Clinical Trial Update: A Novel Therapeutic Treatment of Pyoderma Gangrenosum [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a novel treatment for Pyoderma gangrenosum has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyoderma Gangrenosum

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: Pyoderma Gangrenosum | Phase 4 | Status: TERMINATED